Ascenta Capital

Ascenta Capital describes itself as a venture firm that invests in biotechnology companies developing multiple therapeutic medicines from a common platform. The firm focuses on early-stage biotech companies — typically those advancing through Phase 1 and Phase 2 clinical trials — and works with them to support their clinical, regulatory, manufacturing, and capital strategy needs.